BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haseeb M, Pirzada RH, Ain QU, Choi S. Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics. Cells 2019;8:E1380. [PMID: 31684152 DOI: 10.3390/cells8111380] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Giralt I, Gallo-Oller G, Navarro N, Zarzosa P, Pons G, Magdaleno A, Segura MF, Sábado C, Hladun R, Arango D, Sánchez de Toledo J, Moreno L, Gallego S, Roma J. Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. Int J Mol Sci 2021;22:12921. [PMID: 34884726 DOI: 10.3390/ijms222312921] [Reference Citation Analysis]
2 de Araújo ND, Gama FM, de Souza Barros M, Ribeiro TLP, Alves FS, Xabregas LA, Tarragô AM, Malheiro A, Costa AG. Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity. J Immunol Res 2021;2021:6633824. [PMID: 33506055 DOI: 10.1155/2021/6633824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hassan SS, Maqsood N, Wang Q, Tao S, Sadaf S. A panel of epigenetically dysregulated Wnt signaling pathway genes for non-invasive diagnosis of pediatric acute lymphoblastic leukemia. Cancer Biomark 2021. [PMID: 34334378 DOI: 10.3233/CBM-200814] [Reference Citation Analysis]
4 Inamoto Y, Martin PJ, Lee SJ, Momin AA, Tabellini L, Onstad LE, Pidala J, Flowers MED, Lawler RL, Katayama H, Hanash S, Hansen JA. Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation. Blood Adv 2020;4:2409-17. [PMID: 32492155 DOI: 10.1182/bloodadvances.2020001485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Peng Q, Cheng M, Li T, Chen X, Shen Y, Zhu Y, Xu B. Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer. Cancer Cell Int 2020;20:56. [PMID: 32099529 DOI: 10.1186/s12935-020-1142-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Mammadli M, Harris R, Mahmudlu S, Verma A, May A, Dhawan R, Waickman AT, Sen JM, August A, Karimi M. Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic Transplantation. Cancers (Basel) 2021;13:3798. [PMID: 34359702 DOI: 10.3390/cancers13153798] [Reference Citation Analysis]
7 Zhang M, Wang D, Su L, Ma J, Wang S, Cui M, Hong S, Guan B, Ma X. Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference. Front Oncol 2021;11:726034. [PMID: 34540693 DOI: 10.3389/fonc.2021.726034] [Reference Citation Analysis]
8 Jouinot A, Lippert J, Fassnacht M, de La Villeon B, Septier A, Neou M, Perlemoine K, Appenzeller S, Sibony M, Gaujoux S, Dousset B, Libe R, Groussin L, Ronchi CL, Assié G, Bertherat J. Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma. Endocr Connect 2020;9:705-14. [PMID: 32698135 DOI: 10.1530/EC-20-0228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gong Q, Jiang Y, Lu J, You Y. [Fractalkine inhibits lipopolysaccharide-induced M1 polarization of macrophages by activating Wnt/β-catenin signaling pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1726-31. [PMID: 33380403 DOI: 10.12122/j.issn.1673-4254.2020.12.05] [Reference Citation Analysis]
10 Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells 2021;10:142. [PMID: 33445713 DOI: 10.3390/cells10010142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
11 Rong M, Yan X, Zhang H, Zhou C, Zhang C. Dysfunction of Decidual Macrophages Is a Potential Risk Factor in the Occurrence of Preeclampsia. Front Immunol 2021;12:655655. [PMID: 34054819 DOI: 10.3389/fimmu.2021.655655] [Reference Citation Analysis]
12 Suryawanshi A, Hussein MS, Prasad PD, Manicassamy S. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity. Front Immunol 2020;11:122. [PMID: 32132993 DOI: 10.3389/fimmu.2020.00122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
13 Zhao C, Liu Y, Ju S, Wang X. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker. Int J Gen Med 2021;14:7411-22. [PMID: 34744452 DOI: 10.2147/IJGM.S331752] [Reference Citation Analysis]
14 Muhammad S, Chaudhry SR, Kahlert UD, Niemelä M, Hänggi D. Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury. Cells 2021;10:2429. [PMID: 34572077 DOI: 10.3390/cells10092429] [Reference Citation Analysis]
15 Hiremath IS, Goel A, Warrier S, Kumar AP, Sethi G, Garg M. The multidimensional role of the Wnt/β-catenin signaling pathway in human malignancies. J Cell Physiol 2021. [PMID: 34431086 DOI: 10.1002/jcp.30561] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sun M, Chen Z, Wu X, Yu Y, Wang L, Lu A, Zhang G, Li F. The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research. Front Immunol 2021;12:602330. [PMID: 33717084 DOI: 10.3389/fimmu.2021.602330] [Reference Citation Analysis]
17 Giralt I, Gallo-Oller G, Navarro N, Zarzosa P, Pons G, Magdaleno A, Segura MF, Sánchez de Toledo J, Moreno L, Gallego S, Roma J. Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role. Pharmaceuticals (Basel) 2021;14:810. [PMID: 34451907 DOI: 10.3390/ph14080810] [Reference Citation Analysis]
18 Lospinoso K, Dozmorov M, El Fawal N, Raghu R, Chae WJ, Lee ED. Overexpression of ERAP2N in Human Trophoblast Cells Promotes Cell Death. Int J Mol Sci 2021;22:8585. [PMID: 34445292 DOI: 10.3390/ijms22168585] [Reference Citation Analysis]
19 Chow S, Berek JS, Dorigo O. Development of Therapeutic Vaccines for Ovarian Cancer. Vaccines (Basel) 2020;8:E657. [PMID: 33167428 DOI: 10.3390/vaccines8040657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sharma M, Pruitt K. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks. Int J Mol Sci 2020;21:E8018. [PMID: 33126517 DOI: 10.3390/ijms21218018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
21 Zhu H, Du C, Yuan M, Fu P, He Q, Yang B, Cao J. PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer. Drug Discov Today 2020;25:1762-71. [PMID: 32663441 DOI: 10.1016/j.drudis.2020.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
22 Ahmed S, Khan H, Aschner M, Mirzae H, Küpeli Akkol E, Capasso R. Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects. Int J Mol Sci 2020;21:E5622. [PMID: 32781533 DOI: 10.3390/ijms21165622] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
23 Li S, Gao J, Xu Q, Zhang X, Huang M, Dai X, Huang K, Liu L. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors. Front Immunol 2021;12:693314. [PMID: 34177954 DOI: 10.3389/fimmu.2021.693314] [Reference Citation Analysis]
24 Li Y, Li M, Jin F, Liu J, Chen M, Yin J. DNAJC12 promotes lung cancer growth by regulating the activation of β‑catenin. Int J Mol Med 2021;47:105. [PMID: 33907820 DOI: 10.3892/ijmm.2021.4938] [Reference Citation Analysis]
25 Dabrowska M, Uram L, Dabrowski M, Sikora E. Antigen presentation capability and AP-1 activation accompany methotrexate-induced colon cancer cell senescence in the context of aberrant β-catenin signaling. Mech Ageing Dev 2021;197:111517. [PMID: 34139213 DOI: 10.1016/j.mad.2021.111517] [Reference Citation Analysis]
26 Hermel DJ, Du EZ, Lin R, Frenette CT, Sigal DS. Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma. J Clin Transl Hepatol 2021;9:265-8. [PMID: 34007809 DOI: 10.14218/JCTH.2020.00094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Yüksel O, Pehlivan M, Çöven HİK, Çerçi B, Soyöz M, Tatar E, Ayna TK, Pirim İ. The changes in the expression levels of β-catenin gene in pre- and post- Kidney Transplants. Transpl Immunol 2021;69:101471. [PMID: 34537346 DOI: 10.1016/j.trim.2021.101471] [Reference Citation Analysis]